Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain
14
1
2
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
7.1%
1 terminated/withdrawn out of 14 trials
90.9%
+4.4% vs industry average
7%
1 trials in Phase 3/4
10%
1 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Influence of Implant Surface Decontamination on the Reconstructive Outcomes of Peri-implantitis
Role: lead
Reconstructive Therapy of Peri-implantitis with PDGF-BB (Gem-21)
Role: lead
Reconstructive Management of Peri-implantitis
Role: lead
Adjunctive Use of Dermal Matrix to Compensate Dimensional Changes in the Reconstructive Therapy of Peri-implantitis
Role: lead
Compliance and Cumulative Interceptive Rate After Therapy of Peri-implantitis
Role: lead
Implantoplasty as Adjunct to Combined Surgical Therapy of Peri-Implantitis
Role: lead
Understanding, Modulation and Memorization of Indicators Associated to Peri-implantitis
Role: lead
Dimensional Changes of Free Epithelial Graft at Teeth and Implant Sites
Role: lead
Morphological Pattern of the Atrophic Posterior Maxillae
Role: lead
Impact of Buccal Bone Thickness on Pathological Peri-implant Bone Loss: A 3-year Prospective Cohort Study
Role: lead
Association of Keratinised Mucosa Around Implants and Teeth With Peri-implant/Periodontal Disease and Soft Tissue Conditioning
Role: lead
The Morphology of the Peri-Implantitis Defects: A Cone-Beam Computed Analysis
Role: lead
Sensitivity and Specificity of Peri-Implantitis-Related Parameters
Role: lead
Preventive Maintenance Therapy on Peri-implant Diseases
Role: lead
All 14 trials loaded